Curelab Oncology Inc — Form D

Curelab Oncology Inc of DEDHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-12-27. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2022-12-27
• Form: D
• Accession: 0001080368-22-000053
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $3.0M
• Minimum investment: $10K
• Investors: 1
• Date of first sale: 2022-08-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-468753

Issuer

• Name: Curelab Oncology Inc
• CIK: 0001959567
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2019
• Address: 417 GREENLODGE STREET, DEDHAM, MA, 02026
• Phone: 6098411201

Officers, directors & promoters (3)

More

• CIK 1959567 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search